Literature DB >> 28214574

Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database.

Andrew G Bachman1, Alexander A Parker2, Marshall D Shaw2, Brian W Cross2, Kelly L Stratton2, Michael S Cookson2, Sanjay G Patel2.   

Abstract

OBJECTIVE: To examine temporal national trends of operative approach for cystectomy and identify demographic or clinical predictive factors that influence choice of approach.
METHODS: We performed a retrospective cohort study of patients who underwent cystectomy for bladder cancer between 2010 and 2013 using the National Cancer Database. Approach was stratified by open vs minimally invasive (robotic or laparoscopic). Univariate Pearson chi-square and multivariate logistic regression analysis were used to assess the relationships between demographic and hospital factors and the receipt of minimally invasive or open surgical approach.
RESULTS: A total of 9439 patients met our inclusion criteria, of which 34.1% received a minimally invasive approach (MIA). Frequency of MIA increased from 26.3% in 2010 to 39.4% in 2013 (P < .0001). Univariate analysis identified statistically significant associations between year of diagnosis, sex, age, race, clinical T stage, insurance status, income, education, distance from hospital, facility type, geographic location, and facility cystectomy volume, and the choice of approach (all P < .01). On multivariate analysis, independent predictors of MIA included increasing year of diagnosis, male gender, lower clinical T stage, private insurance vs Medicaid, nonacademic vs academic program, northeastern geographic region, receipt of neoadjuvant chemotherapy, and lower cystectomy volume.
CONCLUSION: Utilization of MIA for cystectomy has increased nationally over the last several years likely due to increased surgeon familiarity with robotic laparoscopic pelvic surgery. Factors associated with MIA included male sex, locally confined disease, receipt of neoadjuvant chemotherapy, lower cystectomy volume centers, and nonacademic centers.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28214574     DOI: 10.1016/j.urology.2017.02.018

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

1.  Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.

Authors:  John M Sung; Jeremy W Martin; Francis A Jefferson; Daniel A Sidhom; Keyhan Piranviseh; Melissa Huang; Nobel Nguyen; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Ramy F Youssef
Journal:  Clin Genitourin Cancer       Date:  2019-05-31       Impact factor: 2.872

Review 2.  Artificial intelligence and robotics: a combination that is changing the operating room.

Authors:  Iulia Andras; Elio Mazzone; Fijs W B van Leeuwen; Geert De Naeyer; Matthias N van Oosterom; Sergi Beato; Tessa Buckle; Shane O'Sullivan; Pim J van Leeuwen; Alexander Beulens; Nicolae Crisan; Frederiek D'Hondt; Peter Schatteman; Henk van Der Poel; Paolo Dell'Oglio; Alexandre Mottrie
Journal:  World J Urol       Date:  2019-11-27       Impact factor: 4.226

3.  Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data.

Authors:  Ashwin Sunil Tamhankar; David Thurtle; Alexander Hampson; Omar El-Taji; Ramesh Thurairaja; John D Kelly; James W F Catto; Tim Lane; James Adshead; Nikhil Vasdev
Journal:  BJUI Compass       Date:  2021-03-12

Review 4.  Updates on Robotic Intracorporeal Urinary Diversions.

Authors:  Shawn Dason; Alvin C Goh
Journal:  Curr Urol Rep       Date:  2018-03-15       Impact factor: 3.092

Review 5.  Robotic assisted radical cystectomy versus open radical cystectomy: a review of what we do and don't know.

Authors:  Zeynep G Gul; Andrew B Katims; Jared S Winoker; Peter Wiklund; Nikhil Waingankar; Reza Mehrazin
Journal:  Transl Androl Urol       Date:  2021-05

6.  Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve?

Authors:  Jong Hyun Tae; Jong Hyun Pyun; Ji Sung Shim; Seok Cho; Sung Gu Kang; Young Hwii Ko; Jun Cheon; Jeong Gu Lee; Seok Ho Kang
Journal:  Investig Clin Urol       Date:  2019-10-07

Review 7.  The evolving role of lymphadenectomy for bladder cancer: why, when, and how.

Authors:  Vignesh T Packiam; Matvey Tsivian; Stephen A Boorjian
Journal:  Transl Androl Urol       Date:  2020-12

Review 8.  Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?

Authors:  Timothy N Clinton; Chun Huang; Alvin C Goh
Journal:  Transl Androl Urol       Date:  2020-12

Review 9.  Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use.

Authors:  Nima Almassi; Bernard H Bochner
Journal:  Curr Opin Urol       Date:  2020-05       Impact factor: 2.808

10.  T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate.

Authors:  Andrew Brodie; Nadine McCauley; Jo Cresswell; Nikhil Vasdev
Journal:  Transl Androl Urol       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.